Anavex Life Sciences Stock News

Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q4 2021 Results - Earnings Call Transcript

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Puma Biotech Announces Receipt Of Patent Extension For Breast Cancer Drug By 5 Years Puma Biotechnolog

Webcast and Conference Call Today at 4:30 p.m. Eastern Time Webcast and Conference Call Today at 4:30 p.m. Eastern Time

Webcast and Conference Call Today at 4:30 p.m. Eastern Time Webcast and Conference Call Today at 4:30 p.m. Eastern Time

Anavex Life Sciences (NASDAQ:AVXL) is set to give its latest quarterly earnings report on Wednesday, 2021-11-24. Here's what investors need to know before the announcement.

Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reportin

California State Teachers Retirement System trimmed its stake in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) by 2.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 85,577 shares of the biotechnology companys stock after selling 2,505 shares during the period. California State Teachers Retirement System owned []

Nuveen Asset Management LLC trimmed its position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) by 6.7% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 234,818 shares of the biotechnology companys stock after selling 16,789 shares during the period. Nuveen Asset Management LLCs holdings in Anavex Life Sciences were worth $5,368,000 as []

Webcast and Conference Call To be Held Wednesday November 24, 2021, 4:30 pm EDT Webcast and Conference Call To be Held Wednesday November 24, 2021, 4:30 pm EDT

Webcast and Conference Call To be Held Wednesday November 24, 2021, 4:30 pm EDT Webcast and Conference Call To be Held Wednesday November 24, 2021, 4:30 pm EDT

Webcast and Conference Call To be Held Wednesday November 24, 2021, 4:30 pm EDT Webcast and Conference Call To be Held Wednesday November 24, 2021, 4:30 pm EDT

An Alzheimer's Bubble That Was Well & Truly Burst May Be Blowing Up Again - Here's Why

Cassava Sciences' Simufilam is now seen as the best hope to treat all patients in Alzheimer's disease after disappointment in Cortexyme's data.

Small Pharma Analyst is a veteran of the pharma industry and specializes in the analysis of small pharma companies. The opportunity in small-caps, leveraging their industry experience to gain an edge